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Abstract
Background: Castleman’s disease is a rare form of localized lymph node hyperplasia of uncertain etiology.
Although the mediastinum is the most common site of involvement, rare cases occurring in lymph node bearing
tissue of other localization have been reported, including only a few intramuscular cases. Unicentric and
multicentric Castleman’s disease are being distinguished, the latter harboring an unfavorable prognosis.
Case Presentation: Here, we present a case of unicentric Castleman’s disease in a 37-year-old woman without
associated neoplastic, autoimmune or infectious diseases. The lesion was located in the femoral region of the right
lower extremity and surgically resected after radiographic workup and excisional biopsy examinations. The tumor
comprised lymphoid tissue with numerous germinal centers with central fibrosis, onion-skinning and rich
interfollicular vascularization. CD23-positive follicular dendritic cells were detected in the germinal centers and
numerous CD138-positive plasma cells in interfollicular areas. The diagnosis of mixed cellularity type Castleman’s
disease was established and the patient recovered well.
Conclusions: In conclusion, the differential diagnosis of Castleman’s disease should be considered when evaluating
a sharply demarcated, hypervascularized lymphatic tumor located in the extremities. However, the developmental
etiology of Castleman’s disease remains to be further examined.
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Background
Castleman’s disease is regarded as a polyclonal lymphoid
proliferation of unknown etiology, also designated as
angiofollicular lymph node hyperplasia [1]. It was first
described by Benjamin Castleman in 1954 as “localized
mediastinal lymph node hyperplasia resembling thy-
moma” [2]. The etiology of this uncommon entity is still
unclear and only few studies on the molecular and cyto-
genetic characteristics of this disorder exist [3,4]. The
most common site of involvement is lymph node-bear-
ing tissue with a predilection for the mediastinum
(70%), but also occurring in the neck, axilla, pelvis and
retroperitoeum [5]. However, a few extranodal cases
have been reported in the literature, comprising 9 intra-
muscular cases [6]. Unicentric Castleman’s disease
behaves rather benign and can be cured by surgical
removal, whereas the multicentric variant harbors the
risk of an unfavorable course, and therefore requires an
aggressive multimodal chemotherapy [1,5,6]. Here, we
d e s c r i b eac a s eo fu n i c e n t r i cm i x e dc e l l u l a r i t yt y p eC a s -
tleman’s disease of the lower extremity. We present the
clinico-pathological characteristics with a review of the
literature.
Case Presentation
A 37-year-old woman presented with a two-month history
of a soft tissue mass of the femoral region of the right
lower extremity. Her past medical history was uneventful
and her family history exhibited no malignancies. Physical
examination revealed a well-developed and nourished
woman in no apparent discomfort. Examination of her
heart, lungs and abdomen detected no pathologies. Palpa-
tion revealed a sharply demarcated tumor of hard consis-
tency, fixed to the deep muscles of the medial femoral
region. Laboratory findings were within normal range,
except for a mild leucocytosis of 12,200 cells/μL (reference
range, 4,300-11,300 cells/μL). Magnet resonance imaging
(MRI) detected a homogeneous hyperintense contrast
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right inguinal ligament between the adductor and quadri-
ceps femoris muscle compartment. The tumor showed
entrapment of the femoral artery and vein, but without
compression, and displayed homogeneous contrast
enhancement after intravenous contrast application. These
findings were suggestive of liposarcoma. Excisional biopsy
of the soft tissue mass was performed and histopathologi-
cal examination revealed a lymphoid tumor of unknown
dignity, suggestive of either pseudo-lymphoma or B-cell
lymphoma. However, a primary soft tissue tumor was
ruled out. The mass lesion was closely observed for three
months and a slight decrease in size to 8.5 cm was noticed
by repeated MRI studies (Figure 1A). Then, the tumor was
surgically completely resected and presented as a sharply
demarcated mass lesion (Figure 1B) embedded in hemor-
rhagic soft tissue with a homogeneous brown-yellow cut
surface and areas of calcification. On microscopic view,
the tumor consisted of lymphoid tissue with numerous
germinal centers with central fibrosis and rich interfollicu-
lar vascularization. Some lymph follicles showed the typi-
cal onion-skinning of lymphocytes concentrically
surrounding germinal centers (Figure 1C), sometimes
penetrated by a hyalinized blood vessel resembling a “lolli-
pop”. Other follicles displayed hyperplastic germinal cen-
ters with an infiltration of the mantle zone by mature
plasma cells. Immunohistochemical staining with CD5
(DCS, Hamburg, Germany) revealed CD5-positive lym-
phoid cells at the periphery of the abnormal follicles (Fig-
ure 1D). Follicular dendritic cells located in the germinal
centers showed positive staining for KiM4P (clone KiM4P,
Kiel, Germany) (Figure 1E) and CD23 (Neo Markers, Fre-
mont CA, USA), and numerous CD138-positive (Dako,
Glostrup, Denmark) plasma cells were scattered through
the interfollicular areas (Figure 1F). To test clonal immu-
noglobulin heavy chain gene rearrangements the indenti-
clone immunoglobulin heavy chain (IGH) gene clonality
assay (InVivoScribe Technologies, San Diego, CA, USA)
was used showing no monoclonal B-cell proliferation.
Molecular testing (i. e. EBER in-situ hybridization and
EBV-PCR) for Epstein-Barr virus (EBV) was negative. His-
tological examination confirmed complete tumor resec-
tion. Finally, the diagnosis of Castleman’s disease of mixed
hyaline vascular and plasma cell type (i. e. mixed cellularity
type) was established and confirmed by a reference pathol-
ogist. The patient recovered well and was dismissed 5 days
after the operation. No associated diseases, especially no
evidence of infection with human immunodeficiency virus
(HIV), could be detected. Computed tomography (CT)
workup examinations after 3 months revealed no evidence
of relapse or manifestations at other sites.
Written informed consent was obtained from the
patient for publication of this case report and any
accompanying images.
Castleman’s disease is a rare disorder arising predomi-
nantly in young adult patients without a gender predo-
minance [6]. Based on clinical and radiological findings
Castleman’s disease is classified as unicentric vs. multi-
centric disorder [5]. Only 9 cases of intramuscular Cas-
tleman’s disease have been reported with a female
predominance (7 women vs. 2 men), occurring between
the age of 14 and 48 years [6]. Most of these cases
developed in the shoulder girdle with only one case aris-
ing in the lower extremity (peroneal muscle) [6]. Here,
Figure 1
Figure 1 Radiographic, gross and histopathological findings of
resected unicentric Castleman’s disease. T1-weighed magnet
resonance imaging revealed a sharply demarcated hyperintense
mass lesion of 8.5 × 6 × 3.5 cm, located between the adductor and
quadriceps femoris muscle surrounding the femoral vessels (A,
arrow). Grossly, the resected tumor specimen displayed a single
well-circumscribed round nodule covered by hemorrhagic soft
tissue (B). On microscopic view, the tumor consisted of lymphoid
tissue with numerous germinal centers with central fibrosis and
marked vascularization. Some lymph follicles showed germinal
centers with concentric onion skin-like layering of surrounding
lymphoid cells (C). Immunohistochemical staining with CD5
revealed CD5-positive lymphocyte at the periphery of the follicles
(D), whereas the follicular dendritic cells in the germinal centers
expressed KiM4P (E). The spaces between the lymph follicles (stars)
were filled out with CD138-positive plasma cells (F) (× 100).
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extremity with inter-compartmental localization but
probable origin in lymph nodes along the femoral artery
since the tumor encased the femoral artery and vein.
Whether previously described intramuscular cases devel-
oped actually from skeletal muscle or from ectopic lym-
phatic tissue remains to be discussed. In the present
case a primary soft tissue tumor was suspected clinically.
The establishment of the correct preoperative diagnosis
of Castleman’s disease by histopathological examination
of excisional biopsies is challenging due to the rarity of
this entity, especially when the tumor arises in the extre-
mities [6]. Deep biopsy and careful tissue sampling are
necessary to render the hyaline vascular parts with
lymph follicles with aberrant and shrunken germinal
centers with concentric onion skin-like arrangement of
lymphocytes and “lollipop” formations suggestive of Cas-
tleman’s disease [6]. Additionally, the characteristic
hypervascularization causes homogeneous contrast
enhancement in MRI and CT imaging [6]. Radiological
differential diagnoses include vascular tumors, extra-
pleural solitary fibrous tumors, malignant lymphoma,
soft tissue sarcoma and metastases [6].
Still, the etiology of Castleman’s disease is poorly
understood. Since monoclonal lymphocyte proliferation
is not present, the disease may be of reactive nature.
Clinical and radiologic findings discriminate a unicentric
and a multicentric subtype. Based on histopathology
Castleman’s disease can be subdivided into a hyaline
vascular (90%) and plasma cell type (10%) [7]. The hya-
line vascular type mostly presents as a single unicentric
mass harboring a favorable prognosis, whereas the
plasma cell type is almost always multicentric and asso-
ciated with a worse prognosis [6,7]. Altogether, the
unicentric hyaline vascular type is most frequent,
accounting for 72% of all cases, followed by the uni-
centric plasma cell (18%), and multicentric type (10%),
respectively [6]. Table 1 summarizes the clinico-patholo-
gical characteristics of the different subtypes of Castle-
man’s disease and the present case. Histopathological
differential diagnoses include benign and malignant lym-
phoproliferative disorders such as pseudo-lymphoma,
low-grade MALT (mucosa-associated lymphoid tissue)-
type lymphoma, and follicular lymphoma [6]. Constitu-
tional symptoms such as fever, night sweats and elevated
interleukin-6 levels have been reported in the literature
[6]. On microscopic examination the hyaline vascular
type is characterized by abnormal follicles with shrun-
ken germinal centers consisting of follicular dendritic
cells, onion skinning, ingrowing hyalinized vessels,
resembling a lollipop, and interfollicular hypervasculari-
zation. In contrast, the plasma cell variant typically
shows hyperplastic germical centers, intact mantle zone
infiltrated by mature plasma cells, and interfollicular
plasmacytosis. In the present case, both features were
observed, and the tumor classified as the “mixed cellu-
larity” variant.
The developmental etiology of Castleman’s disease is
still being discussed. In the hyaline vascular type CD5-
positive lymphocyte proliferations, possibly stimulated
by certain cytokines, have been suggested to play a role
in the development of the disease [8]. Some authors
even designate this subtype as an “atypical CD5-positive
B-cell disorder” whereas others propose a disease of fol-
licular dendritic cells [8,9]. In our case, CD5-positive B-
cells were detected in the periphery of the germinal cen-
ters surrounding the follicular dendritic cells. Cytoge-
netic anomalies detected in stromal cells in hyaline
Table 1 Clinico-pathological characteristics of different subtypes of Castleman’s disease as described in previous
studies
1-10 and the present case
Histologic
subtype
Predominant
occurence
Epidemiology Morphology Immuno-
histochemistry
Associated diseases Clinical
course
Therapy
Hyaline
vascular
Unicentric F = M, young
adults
Abnormal follicles with
shrunken germinal centers
consisting of FDC, “onion
skinning”, vascular ingrowth:
“lollipop” formations,
interfollicular hypervasculariza-
tion
FDC: CD21,
CD35, EGFR
Nephrotic syndrome,
mixed connective tissue
disorder, Hodgkin
disease
Benign Complete
resection
Plasma cell Multicentric F = M, young
adults
Hyperplastic germical centers,
intact mantle zone infiltrated
by mature plasma cells,
interfollicular plasmacytosis
Plasma cells:
CD138
Elevated IgG4, elevated
IL-6; infections: HHV-8,
HIV; autoimmune,
paraneoplastic and
connective tissue
diseases
Aggressive Multimodal
approach:
radiation,
chemo-
therapy, and/
or surgery
Mixed
cellularity
(present
case)
Unicentric F, 37 years A combination of hyaline
vascular and plasma cell type
FDC: CD23,
KiM4P; Plasma
cells: CD138
None Benign Complete
resection
FDC: Follicular dendritic cells.
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and t(7;8)(q37.3;q12) [3]. Furthermore, rearrangement
and partial deletion of the HMGIC gene in follicular
dendritic cells due to an unbalanced 6;12 translocation
has been reported, suggesting a clonal proliferation of
follicular dendritic cells the hyaline vascular subtype [9].
Some reports describe a possible association with the
development of angiomyoid proliferative lesions and
vascular tumors and a possible mesenchymal tumorigen-
esis being implicated in hyaline vascular Castleman’s
disease [9]. An association of the multicentric type with
an human herpes virus (HHV)-8 infection in HIV-posi-
tive patients has recently been discovered [4]. HIV,
other conditions of immune deregulation and primary
auto-immune diseases (systemic lupus erythematosus,
POEMS syndrome, nephrotic syndrome) may even exhi-
bit histologic findings similar to Castleman’sd i s e a s e ,
including regressive lymph nodes [5,8]. Furthermore,
excessive production of interleukin-6 in germinal cen-
ters of multicentric Castleman’s disease has been
observed to be associated with an HHV-8 infection and
it has been suspected to play an important role in the
pathophysiology [5,7,10]. However, in the present case
no constitutional symptoms or related disorders could
be observed as yet.
Conclusions
Although infrequent, it is important to bear the differen-
tial diagnosis of Castleman’s disease in mind when eval-
uating a sharply demarcated, hypervascularized
lymphatic hyperplasia located in the extremities. The
etiology of Castleman’s disease remains to be further
examined in future studies.
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